NCT01710592View on ClinicalTrials.gov

A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2012

Conditions

Gastro Oesophageal Cancer

Interventions

DRUG

Epirubicin

DRUG

Oxaliplatin

DRUG

Capecitabine

DRUG

Docetaxel

Trial Locations (6)

Unknown

Mercy University Hospital, Cork

Beaumont Hospital, Dublin

Mater Misericordiae University hospital & Mater Private Hospital, Dublin

St James's Hospital, Dublin

The Adelaide and Meath Hospital, Dublin

Waterford Regional Hospital, Waterford

All Listed Sponsors

lead

Cancer Trials Ireland

NETWORK

NCT01710592 - A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer | Biotech Hunter | Biotech Hunter